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Background: -Transaminases are promising biocatalysts for the synthesis of -amino acids.
Results: The first three-dimensional structures were obtained of a native -transaminase and complexes with a keto acid and
two covalently bound -amino acids.
Conclusion: Dual functionality of the carboxylate- and side chain-binding pockets allows binding of - and -amino acids.
Significance: These structures may facilitate the development of improved -amino acid biocatalysts.
Chiral -amino acids occur as constituents of various natural
and synthetic compounds with potentially useful bioactivities.
The pyridoxal 5-phosphate (PLP)-dependent S-selective trans-
aminase fromMesorhizobium sp. strain LUK (MesAT) is a fold
type I aminotransferase that can be used for the preparation of
enantiopure -Phe and derivatives thereof. Using x-ray crystal-
lography, we solved structures ofMesAT in complex with (S)--
Phe, (R)-3-amino-5-methylhexanoic acid, 2-oxoglutarate, and
the inhibitor 2-aminooxyacetic acid, which allowed us to unveil
the molecular basis of the amino acid specificity and enantiose-
lectivity of this enzyme. The binding pocket of the side chain of
a-amino acid is located on the 3-oxygen side of the PLP cofac-
tor. The same binding pocket is utilized by MesAT to bind the
-carboxylate group of an -amino acid. A -amino acid thus
binds in a reverse orientation in the active site of MesAT com-
pared with an -amino acid. Such a binding mode has not been
reported before for any PLP-dependent aminotransferase and
shows that the active site of MesAT has specifically evolved to
accommodate both - and -amino acids.
-Amino acids occur as precursors of many natural and syn-
thetic compounds that display a wide range of pharmacological
activities. Altering and improving the pharmacological proper-
ties of these compounds critically depend on the availability of
-amino acids and their derivatives as building blocks. There-
fore, several strategies for the synthesis of -amino acids have
been explored over the years, involving either synthetic (1, 2) or
combined chemoenzymatic (3) methods. However, fully
enzyme-based synthesis methods have clear advantages over
synthetic or chemoenzymatic methods (4) and have the poten-
tial to increase the feasibility of biocatalytic or fermentative
routes toward -amino compounds.
Pyridoxal 5-phosphate (PLP)3-dependent aminotrans-
ferases (also called transaminases) are attractive for the produc-
tion of amino acids because they have a broad substrate range,
can be highly enantioselective, show a high catalytic activity,
and are relatively stable (5). Aminotransferases catalyze the
transfer of an amino group from an amino compound to a keto
acid. In the first half-reaction, the amino group of the amino
compound replaces the covalent Schiff base linkage, or imine
bond, between the -amino group of a lysine and the C4A atom
of the PLP cofactor, generating an external aldimine (Fig. 1).
Lysine-assisted transfer of a proton from the external aldimine
to the C4A atom of the cofactor results in a ketimine interme-
diate, which is hydrolyzed to yield pyridoxamine phosphate
(PMP). Subsequently, in the second half-reaction, the amino
group of PMP is transferred to a keto acid, which generates a
new amino compound (Fig. 1) (6).
The production of -amino acids using PLP-dependent ami-
notransferases has been demonstrated for an -transaminase
from Polaromonas sp. strain JS666 (7) and a -transaminase
fromMesorhizobium sp. strain LUK (MesAT) (8). The genes of
these two enzymes were successfully cloned and expressed in
Escherichia coli BL21(DE3) using pET-based expression sys-
tems (7, 8), and MesAT has been crystallized (9). MesAT is an
enzyme of 445 amino acids with molecular weight of 45 kDa,
forms dimers in solution, and accepts - and -amino acids (8,
10). The enzyme can convert the aliphatic -amino acids (R)-
3-amino-5-methylhexanoic acid and (R)-3-aminobutyric acid
and the aromatic -amino acid (S)--Phe to the corresponding
-keto acids using pyruvate or 2-oxoglutarate as the amino
acceptor. In the reverse reaction, MesAT can be used to pro-
duce (S)--Phe from its -keto acid ethyl ester in a coupled
enzyme reaction containing a lipase to generate the keto acid in
situ and rac-3-aminobutyric acid as amino donor (8). Unfortu-
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nately, the more stable keto ester is a very poor substrate for
aminotransferase-mediated conversion to (S)--Phe.
Information on three-dimensional structures of -amino-
transferases is currently lacking. To enable rational protein
engineering approaches for improving the activity of the
enzyme for application in the biosynthesis of-amino acids, we
have elucidated the crystal structure of MesAT in the native
state, as well as in complex with -amino acids, a keto acid, and
an inhibitor. The structure of the enzyme conforms to a fold
type I aminotransferase structure, but the hydrophobic binding
pocket is located on the 3-oxygen side of the PLP cofactor
rather than on its phosphate side as found in other aminotrans-
ferases. On the other hand, an -amino acid binds in a normal
orientation, with the -carboxylate on the 3-oxygen side and
the side chain of the amino acid on the phosphate side of the
PLP cofactor. The architecture of the active site explains how
MesAT can accept - and -amino acids (8), whereas the aro-
matic -amino acid aminotransferase (AroAT) from Paracoc-
cus denitrificans (11) and most other aminotransferases accept
only -amino acids. The structure also explains the stereo pref-
erence of the enzyme for - and -amino acids.
EXPERIMENTAL PROCEDURES
Protein Expression and Purification—The MesAT gene was
codon-optimized for E. coli, synthesized by DNA2.0, Inc., and
cloned into the expression plasmid pET28b with an N-termi-
nal His6 tag usingNdeI/HindIII restriction sites. After transfor-
mation into E. coli BL21(DE3), cells were grown at 37 °C in 1.4
liters of Terrific broth/sorbitol medium (12) containing 50
g/ml kanamycin. Protein expressionwas inducedwith 0.4mM
isopropyl -D-thiogalactopyranoside when the absorbance of
the culture at 600 nm reached 0.6–0.8, and the temperature
was adjusted to 17 °C. The cells were grown for another 48 h;
harvested; and resuspended in buffer containing 20 mM Tris-
HCl (pH 8.0), 500 mMNaCl, 20 mM imidazole, 1 mg of DNase I
(Roche Applied Science), and one cOmplete EDTA-free prote-
ase inhibitor tablet (Roche Applied Science). The cells were
disrupted at 4 °C by sonication, followed by centrifugation at
31,000 g for 1 h at 4 °C.
The supernatant was applied to a HisTrap HP affinity chro-
matography column (GE Healthcare), and after washing,
MesATwas eluted with 15 column volumes of a linear gradient
of 20–500mM imidazole in elution buffer (20mMTris-HCl (pH
8.0) and 500 mM NaCl). The fractions corresponding to the
peak were pooled, and the imidazole was removed by buffer
exchange using a HiPrep 26/10 desalting column (GE Health-
care) equilibrated with 25 mM Tris-HCl (pH 8.0) and 0.01%
(v/v) -mercaptoethanol. The resulting protein fractions were
applied to a Q-Sepharose HP anion exchange column (GE
Healthcare) and eluted with 15 column volumes of a linear gra-
dient of 0–1 MNaCl in 25 mM Tris-HCl (pH 8.0). The fractions
containing active enzyme were pooled, concentrated (Ultracel,
Mr 30,000 cutoff, Amicon), and applied to a Superdex 200
10/300GL size exclusion chromatography column (GEHealth-
care) equilibratedwith 20mMTris-HCl (pH8.0) containing 200
mMNaCl. After elution, the fractions corresponding to the pro-
tein peak were pooled, concentrated (Amicon), and dialyzed
overnight against buffer containing 20 mM Tris-HCl (pH 7.5).
The sample was subsequently concentrated to 10 mg/ml as
judged by a protein assay, and the purity of the sample was
checked with silver-stained SDS-polyacrylamide gels using a
PhastSystem (GE Healthcare).
Mutagenesis—The R412A mutant gene of MesAT (supple-
mental Table S2) was constructed by site-directedmutagenesis
(QuikChange, Stratagene) and transformed into E. coli DH5
ElectroMAX electrocompetent cells (Invitrogen). For overex-
pression, E. coli BL21(DE3) was used. The mutant construct
was confirmed by sequence analysis (GATC Biotech).
Protein Crystallization—A Mosquito crystallization robot
(TTP LabTech) was used to search for suitable crystallization
conditions. Crystallization experiments were set up at 20 °C.
Crystals were found in a JCSG Suite (Qiagen) condition con-
taining 0.1 MHEPES (pH 7.5), 8% (v/v) ethylene glycol, and 10%
(w/v) PEG 8000. After optimization, it was found that this was
also the optimal condition for crystal growth, with crystals
reaching sizes of 80 50 30m. Crystals were transferred to
a cryoprotection solution consisting of mother liquor with 20%
FIGURE 1. Half-reactions catalyzed byMesAT, a -specific PLP-dependent transaminase. An amino acid ((S)--Phe) enters the active site of the enzyme
(Enz) (step 1), and an external aldimine is generated. Lys-280, a base, abstracts the C proton (step 2) and transfers the proton to the C4A atom (1,3-prototropic
shift; not shown), which results in the ketimine intermediate. Hydrolysis of the ketimine intermediate results in the formation of PMP and a keto acid
(3-oxo-3-phenylpropanoic acid) (step 3).
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(v/v) ethylene glycol. This was done in four steps of 5 min each,
starting with a solution containing 2% (v/v) ethylene glycol,
followed by solutions of 5, 10, and finally 20% (v/v) ethylene
glycol. Crystals from this last solution were cryo-cooled in liq-
uid nitrogen. For amino acid binding studies, the same steps
were followed, but with the cryoprotection solutions supple-
mented with 2, 5, 10, and 20 mM (S)--Phe (PepTech Corp.),
(R)-3-amino-5-methylhexanoic acid (Fluorochem), 2-oxo-
glutarate disodium salt (Fluka), or 2-aminooxyacetic acid
(AOA) (Aldrich).
Diffraction Data Collection and Processing—Diffraction data
were collected at beamlines ID14-1 and ID14-2 of the European
SynchrotronRadiation Facility (ESRF,Grenoble, France) and at
beamline X13 of the European Molecular Biology Laboratory
Outstation at the Deutsches Elektronen-Synchrotron (DESY,
Hamburg, Germany). Reflections were indexed and integrated
using XDS (13), and scaling and merging of the data were done
with the program SCALA (14) from the CCP4 Software Suite
(15). Phaser (16) was used for molecular replacement with a
mixed input model generated by the FFAS03 server (17) on the
basis of the structures of glutamate-1-semialdehyde 2,1-amino-
mutase from Thermus thermophilus strain HB8 (Protein Data
Bank code 2E7U), D-phenylglycine aminotransferase from
Pseudomonas stutzeri strain ST-201 (code 2CY8), and 4-ami-
nobutyrate aminotransferase from pig (code 1OHV (18)). The
resulting model was subjected to successive rounds of auto-
matic model building with ARP/wARP (19), followed by man-
ualmodel building in Coot (20). REFMAC5was used for refine-
ment of the atomic coordinates and atomic B-factors (21). Data
collection and refinement statistics are given in supplemental
Table S3. After refinement, the model was validated with Mol-
Probity (22). Stereochemical restraints for the amino acid ana-
logs were generated using the PRODRG2 server (23). Root
mean square deviations (r.m.s.d.) were calculated with the
RMSDcalc tool of the CaspR server (24), and structural
homologs of MesAT were obtained from the Dali server (25).
PISA from the CCP4 Software Suite was used for protein inter-
face analysis (26). Simulated annealing composite omit maps
where generated with PHENIX (27). Chemical structure draw-
ings were made using the ChemDraw program (Cambridge-
Soft), and PyMOL (28) was used to generate images of the pro-
tein structure.
Enzyme Assay and Analytical Methods—Aminotransferase
assayswere performedwith 10mMaminodonor ((S)--Phe), 10
mM amino acceptor (pyruvate), and enzyme at 37 °C in 50 mM
MOPS (pH 7.6) containing 50 M PLP (Acros Organics). Sam-
ples were taken at different times and treated according to the
following procedure: to 50 l of sample was added 50 l of 2 M
HCl to quench the reaction. The samplewas left on ice for 5min
and neutralized by adding 45 l of 2 M NaOH, followed by
adding 50 l of demineralized water. In an HPLC autosampler
(Jasco), 1-l sample was mixed with 2 l of o-phthalaldehyde
(Sigma) solution (15 mg of o-phthalaldehyde was dissolved in
50l of absolute ethanol, which was thenmixedwith 4.42ml of
0.4 M sodium borate (pH 10.4), 15 l of 30% (w/v) Brij 35
(Fluka), and 11 l of -mercaptoethanol) and 5 l of 0.4 M
sodium borate (pH 10.4). The o-phthalaldehyde-derivatized
sampleswere analyzed byHPLCusing aAlltechAdsorbosphere
C18 column (5 m, 4.6  100 mm) in a Jasco HPLC system.
Separation of o-phthalaldehyde-derivatized imines was
achieved at room temperature at a flow rate of 1ml/min using a
gradient of eluent A (5% THF in 20 mM sodium acetate (pH
5.5)) and eluent B (99% pure CH3CN) as follows: start with
100:0 eluentA/eluent B for 5min; change from100:0 to 80:20 in
7 min; continue with 80:20 for 4 min; change from 80:20 to
40:60 in 8 min; continue with 40:60 for 6 min; change from
40:60 to 100:0 in 2 min; and finally continue for 5 min at 100:0
for re-equilibration of the column. The eluate was analyzed by
UV light (338 nm) using a Jasco UV-2075 Plus detector and a
Jasco FP-920 fluorescence detector (350 nm excitation and 450
nm emission). Retention times for derivatized L--alanine and
(S)--Phe were 7.7 and 23.2 min, respectively. One unit of
enzyme activity is defined as the amount of enzyme that pro-
duces 1 mol/min alanine from 10 mM pyruvate (sodium salt;
Fluka) and 10 mM (S)--Phe (Acros Organics).
Todetermine theVmax andKm values of theR412Amutant of
MesAT, initial rate assays were done with varying concentra-
tions of (S)--Phe or pyruvate, fixing the non-variant substrate
at 10 mM. The reactions were started by adding 680 g of puri-
fied protein and incubating at 37 °C. Inhibition studies were
performed by preincubating the reaction mixture (lacking (S)-
-Phe but containing 40 g of wild-type enzyme) with 5 mM
AOA or 5 mM DL-propargylglycine (2-amino-4-pentynoic acid;
Sigma-Aldrich) for 5 min, after which (S)--Phe was added.
RESULTS
Overexpression, Purification, and Enzyme Activity Measure-
ments of Wild-type and R412AMesAT—Previously, an overex-
pression system ofMesAT was reported that gave a yield of 1.4
mg of pure protein/liter of culture (8). To obtain enhanced
expression, we used a codon-optimized synthetic gene that was
equipped with an N-terminal His tag, cloned it under the con-
trol of the T7 promoter in a pET vector, and cultivated the
transformed E. coli BL21(DE3) cells in Terrific broth/sorbitol
medium at 17 °C. This resulted in an expression level that
allowed the isolation of10mg of pure enzyme/liter of culture
(supplemental Table S1). The specific activity of the purified
wild-type enzyme was 1.6 units/mg, which is similar to what
was reported previously (8).
Structure Determination of MesAT—The holoenzyme crys-
tallizes in space groupC2with threemolecules (chainsA, B, and
C) per asymmetric unit. The three-dimensional structure of
MesATwas elucidated at 2.5Å resolution bymolecular replace-
ment and refined at 1.65 Å resolution. No density is defined for
the first 30 N-terminal residues and the C-terminal residue
Met-445. The three molecules are very similar to each other,
with r.m.s.d. values for the C atom positions of0.2–0.25 Å.
The threemolecules form1.5 dimer in the asymmetric unit; one
dimer consists of chainsA andB (supplemental Fig. S1), and the
other dimer is made up of chain C and a chain C from a neigh-
boring asymmetric unit related by crystallographic 2-fold sym-
metry. Both dimers are very similar, with r.m.s.d. values in the
order of 0.2 Å (C atoms). The two chains in the dimer interact
tightly, burying a surface area of4400 Å2, which is one-quar-
ter of their total surface area. The presence of dimers in the
Structural Determinants of MesAT-Selectivity
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crystal is in agreement with the occurrence ofMesATdimers in
solution (10).
Structure of the MesAT Monomer—The MesAT monomer
has a curved shape and consists of a PLP-binding domain (res-
idues 112–334) and a domain formed by the N and C termini of
the polypeptide chain (NC-domain; residues 1–111 and 335–
445) (supplemental Fig. S1). These two domains line a cleft into
which the PLP cofactor protrudes. The monomer contains 11
-helices (of at least two or more turns) and 13 -strands that
form a mixed central seven-stranded -sheet in the large
domain and 2 three-stranded antiparallel -sheets in the NC-
domain (supplemental Fig. S1). The overall structure is similar
to that of aspartate aminotransferase, the archetypical repre-
sentative of fold type I aminotransferases (Z-score of 21,
r.m.s.d. of 4.2 Å for 309 C atoms, and 16% sequence identity;
Protein Data Bank code 1BKG) (29, 30), and AroAT from
P. denitrificans (Z-score of 21, r.m.s.d. of 4.8 Å for 326 C
atoms, and 15% sequence identity; code 1AY4) (11, 31), which is
specific for L--Phe.
PLP Cofactor—EachMesATmonomer contains a PLP cofac-
tor covalently anchored via an imine bond (Schiff base) to the
-amino group of Lys-280. The amide protons of Gly-145, Thr-
146, and Thr-314 (from monomer B in the case of the AB
dimer) anchor the phosphate group of the PLP cofactor to the
protein backbone. The pyridine ring of the PLP cofactor is
stacked between Val-255 (at the si-face of the pyridine ring
(32)) and Tyr-172 (at the re-face of the pyridine ring). The
nitrogen atom of the pyridine ring is in hydrogen bonding dis-
tance of Asp-253. These interactions keep the PLP cofactor
secured in the active site.
Binding of (S)--Phe—To analyze how (S)--Phe binds in the
active site, a crystal structure ofMesAT with bound (S)--Phe
was solved at 1.7 Å resolution. (S)--Phe binds covalently to the
PLP cofactor via its -amino group, replacing the imine bond
between the -amine of Lys-280 and the C4A atom of the PLP
cofactor (Fig. 2A). It binds with an estimated occupancy of
80% in the three subunits. The carboxylate group of (S)--
Phe has a salt bridge interaction with the N and N2 atoms of
Arg-54. The aromatic ring of (S)--Phe is bound between the
side chains of Tyr-89 and Tyr-172 with edge-to-face interac-
tions (Fig. 2A) and also has van der Waals interactions with
Ile-56, Ala-225, Met-256, and Met-414 from monomer A and
with Ala-312 frommonomer B; these residues line a hydropho-
bic binding pocket that is capped by Arg-412 (monomer A).
Thus, residues from both monomers A and B contribute to the
binding of the aromatic side chain of (S)--Phe. The side chain
amino group of Lys-280 is close to the C R-proton of (S)--
Phe (3.3Å), in agreementwith its role in proton transfer (Fig. 1).
The binding of (S)--Phe does not induce large-scale confor-
mational changes or domain movements inMesAT. Only local
conformational changes have occurred (see “Discussion”).
In monomer A, a second (S)--Phe molecule is present in a
surface pocket, with its aromatic ring stacked between Leu-269
and Leu-368. Its carboxylate and amino groups point into the
solvent and do not interact with the protein. However, in the
surface pockets of monomers B and C, electron density is pres-
ent only for the aromatic ring of an (S)--Phemolecule, but not
for the amino and carboxylate groups. From this, we conclude
that (S)--Phe binds nonspecifically in this surface pocket.
Binding of (R)-3-Amino-5-methylhexanoic Acid—To investi-
gate how an aliphatic -amino acid such as (R)-3-amino-5-
methylhexanoic acid (8) binds in the active site, a 1.95 Å reso-
lution crystal structure was determined of MesAT in complex
with this compound. (R)-3-Amino-5-methylhexanoic acid
FIGURE2.Stereo figuresof simulatedannealing composite2mFoDFcomitmaps contouredat1.A, (S)--Phe (magenta) bound to thePLP cofactor. For
clarity, Tyr-172hasbeenomittedhere and inB–D.B, (R)-3-amino-5-methylhexanoic acid (magenta). For clarity, Ala-312hasbeenomittedhere aswell as inCand
D. C, 2-oxoglutarate (magenta) bound in the active site ofMesAT. LLP, 2-lysine 3-hydroxy-2-methyl-5-phosphonooxymethylpyridin-4-ylmethane, the internal
aldimine. D, AOA (magenta), a -alanine mimic, bound in the active site ofMesAT.
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binds covalently to the PLP cofactor via its -amino group,
replacing the imine bond between the -amine of Lys-280 and
the C4A atom of the PLP cofactor (Fig. 2B). It binds with an
estimated occupancy of 90% in the three subunits. The car-
boxylate group of (R)-3-amino-5-methylhexanoic acid has a
salt bridge interaction with the N and N2 atoms of Arg-54,
and the aliphatic side chain (C4, C5, and C6 atoms) binds in the
hydrophobic binding pocket, where also the aromatic side
chain of (S)--Phe was observed to bind (see above). Binding of
(R)-3-amino-5-methylhexanoic acid produces only limited
local conformational changes inMesAT.
Binding of 2-Oxoglutarate—To analyze how a keto acid binds
in the active site ofMesAT, we determined the crystal structure
of the enzyme with bound 2-oxoglutarate at 1.85 Å resolution
(Fig. 2C). The compound binds noncovalently in the active site.
Its-carboxylate has a bidentate salt bridge interactionwith the
N1 and N2 atoms of Arg-412. The -carboxylate binds with
one of its oxygen atoms to theN andN2 atoms of Arg-54; the
other oxygen atom is not involved in hydrogen bond formation.
The keto oxygen atomof 2-oxoglutarate is located at 3.0 Å from
the nitrogen atom of the Lys-280 side chain, which is covalently
bound to the C4A atom of the PLP cofactor. The binding of
2-oxoglutarate thus leaves the internal aldimine intact. The ori-
entation of 2-oxoglutarate in the active site ofMesAT suggests
that amino group transfer from PMP results in the synthesis of
L-glutamate, in agreement with chiral HPLC analysis of the
product of a reactionwith (S)--Phe as aminodonor and 2-oxo-
glutarate as amino acceptor (data not shown). Binding of 2-oxo-
glutarate does not result in large-scale conformational changes
inMesAT. However, Arg-412 reorients its side chain such that
its N1 and N2 atoms can make a salt bridge interaction with
the -carboxylate of 2-oxoglutarate. This reorientation of the
arginine side chain in response to the binding of an amino acid
in the active site of an aminotransferase is referred to as the
“arginine switch” (33).
The importance of Arg-412 for activity was confirmed by
mutagenesis. The protein yield of theR412Avariantwas similar
to that of the wild-type enzyme. The kcat values of the R412A
mutant were significantly lower than those of the wild-type
enzyme (Table 1). Furthermore, the Km value for pyruvate had
increased by a factor of 28, whereas that for (S)--Phe had
decreased by a factor of 4. The relationship between the reac-
tion rate of the R412Amutant and the substrate concentration
indicated substrate inhibition, as observed in the wild-type
enzyme (Table 1) (34).
Binding of AOA—AOA (35) and 2-amino-4-pentynoic acid
(propargylglycine) (36, 37) are known inhibitors of aminotrans-
ferase activity. Preincubation ofMesATwith these inhibitors at
5 mM resulted in activity decreases of 10% upon treatment with
dl-propargylglycine and of 96% upon treatment with AOA.
Analysis of the 1.9 Å resolution crystal structure ofMesATwith
bound AOA (Fig. 2D) shows that the amino group of AOA
binds covalently to the C4A atom of PLP, as has also been
observed for the interaction of AOA with aspartate amino-
transferase (38). The ether oxygen atom (O1) is close to Lys-
280 (2.9 Å), and the carboxylate group binds via a salt bridge to
the N and N2 atoms of Arg-54. The binding of AOA to the
PLP cofactor is irreversible; the amine–O1 bond cannot be
weakened by Lys-280. Binding of AOA to the PLP cofactor thus
prevents PMP formation and thereby inhibits aminotransferase
activity. No significant conformational changes are observed
upon AOA binding.
DISCUSSION
Structure of MesAT—The structure of MesAT presented
here is the first structure of a transaminase with specificity
toward-amino acids aswell as-amino acids. The structure of
the enzyme is similar to that of aspartate aminotransferase (39),
the archetypical fold type I aminotransferase. The enzyme
assembles into a homodimer, in which residues from both
monomers A and B contribute to the binding of amino acids
and their respective oxo acid substrates. In contrast to aspartate
aminotransferase, the binding of ligands does not induce large
domain movements. Structural changes that do occur in
MesAT upon substrate/inhibitor binding are localized to the
active site and consist of a 16° rotation of the pyridine ring of the
PLP cofactor upon formation of the external aldimine. This
rotation liberates Lys-280 and allows it to function as the pro-
ton-transferring lysine. Another structural change is the rear-
rangement of the Arg-412 side chain, also known as the argi-
nine switch (33), upon binding of 2-oxoglutarate (mentioned
above).
Different Binding Modes of (S)--Phe, (R)-3-Amino-5-meth-
ylhexanoic Acid, and 2-Oxoglutarate—The way in which
2-oxoglutarate binds in the active site ofMesAT and the man-
ner in which (S)--Phe and (R)-3-amino-5-methylhexanoic
acid bind are very different. The side chains of (S)--Phe (Fig.
2A) and (R)-3-amino-5-methylhexanoic acid (Fig. 2B) bind in a
pocket on the 3-oxygen side of the PLP cofactor, which we
denote theO-pocket.However, the side chain of the-keto acid
2-oxoglutarate, a model for the -amino acid L-glutamate,
binds with its -carboxylate group on the phosphate side of the
PLP cofactor (Fig. 2C), in the P-pocket. Thus, MesAT has two
distinct side chain-binding pockets, one for the side chains of
-amino acids (O-pocket) (Fig. 3) and one, on the other end of
the active site, for the side chains of -keto acids and presum-
ably also-amino acids (P-pocket) (Fig. 3). The enzymehas also
two carboxylate-binding pockets; one, involving Arg-54 in the
P-pocket, binds the -carboxylate group of -amino acids and
AOA, a -alanine mimic (Fig. 2D), whereas the other, which
TABLE 1
Specific activity at 37 °C of wild-typeMesAT and the R412Amutant using (S)--Phe as amino donor and pyruvate as amino acceptor
MesAT
Activity (S)--Phe Pyruvate
SourceSpecific Relative Km kcat kcat/Km Ki Km kcat kcat/Km Ki
units/mg % mM s1 s1 mM1 mM mM s1 s1 mM1 mM
WT 1.6 100 1.2a 1.3 1.1 3.2a 3.9a 1.3 0.33 177a Ref. 8
R412A 6 103 0.4 0.29 5 103 2 102 47 109 4.1 102 3.8 104 2500 This study
a Adopted from Kim et al. (8).
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contains Arg-412 in the O-pocket, binds the -carboxylate of
-keto acids such as 2-oxoglutarate (Fig. 2C). As a conse-
quence, an-amino acid and a-amino acid have very different
binding modes inMesAT (Fig. 3, A and B).
Intriguingly, the O-pocket that binds the aliphatic and
hydrophobic side chain of -amino acids also binds the -car-
boxylate group of -keto acids and presumably also of -amino
acids. This dual functionality is made possible by a switch in
position of the Arg-412 side chain, the arginine switch residue
(33). When a -amino acid binds, the Arg-412 side chain is
oriented away from the active site, providing space in the
O-pocket for the hydrophobic side chain of the -amino acid
(Fig. 2, A and B). This orientation of Arg-412 is stabilized by a
hydrogenbondof its side chainN atom to the carbonyl oxygen
atom of Ala-225 (monomer B) (data not shown). In contrast,
upon 2-oxoglutarate binding, the side chain of Arg-412
switches back toward the hydrophobic O-pocket (Fig. 2C); the
hydrogen bond with Ala-225 is broken, and Arg-412 now has a
salt bridge interaction with the -carboxylate of 2-oxogl-
utarate. In this way, the Arg-412 side chain allows the enzyme
to accept both -amino/-keto acids and aliphatic or aromatic
-amino/-keto acids in the same active site. Because of the
dual functionality of the active site pockets ofMesAT,we prefer
to use O- and P-pocket (rather than L- and S-pocket) nomen-
clature, which reflects the presumed size of these pockets (40).
For aminotransferase activity, Arg-412 is virtually essential,
as reflected by the 870- and 55-fold reduction of the catalytic
efficiencies for pyruvate and (S)--Phe, respectively, upon
mutation of this residue to Ala (Table 1). Whereas the
decreased apparentKm for (S)--Phe can be due to the reduced
catalytic rate at 10 mM pyruvate, the increased Km for pyruvate
strongly supports that Arg-412 is important for binding pyru-
vate through electrostatic interactions with its carboxylate.
Comparison of MesAT and AroAT—To investigate how
MesAT differs from an aminotransferase that accepts only -
amino acids, the MesAT structures were compared with
AroAT from P. denitrificans (11). In both enzymes, the PLP
cofactor has a similar position and orientation. In contrast to
MesAT, AroAT has a single -carboxylate-binding pocket, and
charged as well as uncharged -amino acids bind with their
-carboxylate groups to Arg-386 in the O-pocket (Fig. 3, C and
D). In MesAT, the -carboxylate group of (S)--Phe binds to
Arg-54 in the P-pocket, whereas the side chain of (S)--Phe is
bound in the O-pocket (Fig. 3A). As a consequence, inMesAT,
-amino acids bind in a reverse orientation in comparison with
the substrates of AroAT (Fig. 3, A, C, and D). Moreover, the
arginine switch ofMesAT (Arg-412) is located in the O-pocket
of the enzyme, where it binds the -carboxylate group of an
-amino acid, whereas inAroAT, the arginine switch (Arg-292)
is located in the P-pocket of the enzyme and binds the side
FIGURE 3. Comparison of the active site architectures of the-aminotransferaseMesAT (A and B) and the-aminotransferase AroAT (C andD). A and
B, surface renditions of the active site ofMesAT bound to (S)--Phe (magenta) and to 2-oxoglutarate (magenta), respectively. C andD, surface renditions of the
active site of AroAT bound to 3-phenylpropionate (magenta) based on Protein Data Bank code 1AY8 (31) and tomaleate (magenta) based on code 1AY5 (31),
respectively. The positions of the PLP cofactor andArg-412 andArg-386 in the active sites ofMesAT andAroAT, respectively, are similar. Arg-412 represents the
arginine switch of MesAT, and Arg-292 represents the arginine switch of AroAT. LLP, 2-lysine 3-hydroxy-2-methyl-5-phosphonooxymethylpyridin-4-ylmeth-
ane, the internal aldimine. See “Discussion” for explanation of the P-pocket (P) and O-pocket (O).
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chain carboxylate group of -amino/-keto acids (Fig. 3,A–D).
These differences between MesAT and AroAT show that
although these enzymes share the same fold, the architectures
of their active sites are very different. InMesAT, the active site
architecture has evolved to accommodate -amino acids while
retaining the ability to accommodate -amino/-keto acids.
Covalent Adducts in the Active Site of MesAT Represent
External Aldimine Intermediates—Structures obtained from
crystals soaked with (S)--Phe and (R)-3-amino-5-methyl-
hexanoic acid show that covalent PLP–-amino acid adducts
have formed in the active site ofMesAT (Fig. 2,A and B). These
adducts represent external aldimine intermediates because the
N, C, C, and C atoms are not coplanar, as would occur in
the ketimine intermediate (Fig. 1). The non-coplanarity of the
N, C, C, and C atoms suggests that the reaction has
stopped before abstraction of the C proton.
Different explanations for the trapping of the external aldi-
minemay be considered. Proton abstraction is most efficient if,
in the transition state, the bond to be broken is oriented per-
pendicular to the plane of the PLP ring system (41). The crystal
structures indicate that the C proton is indeed nearly perpen-
dicular to the PLP plane, deviating 20–30° from the perpendic-
ular position. Such a deviation is probably not sufficient to fully
prevent proton abstraction.
Another explanation may be related to the observation that
in none of the external aldimine intermediate-bound structures
density is present for a hydrolytic water molecule near the C
atom that could convert the ketimine intermediate into the
pyridoxamine intermediate (Fig. 1). The equilibrium of the
aminotransferase reaction in the crystal structure of MesAT
may thus lie toward the external aldimine intermediate rather
than the ketimine intermediate, which could explain why the
external aldimine intermediates of (S)--Phe and (R)-3-amino-
5-methylhexanoic acid are trapped.
Enantioselectivity of MesAT—MesAT is enantioselective
toward the -amino acids (S)--Phe, (R)-3-amino-5-methyl-
hexanoic acid, and (R)-3-aminobutyric acid (8). These pre-
ferred enantiomers have the same stereo configuration of func-
tional groups on the C atom as (S)--Phe. The preference for
these enantiomers can be fully explained by the architecture of
the active site, which forces these substrates to bind in an ori-
entation in which the carboxylate group binds to Arg-54 in the
P-pocket and the side chain in the O-pocket, followed by addi-
tion of an amino group at the si-face of the -carbon of the
-keto acid. The insights obtained from the three-dimensional
structure ofMesAT upon its interaction with - and -amino/
keto acids may facilitate structure-based protein engineering
efforts to enhance the biocatalytic potential of-transaminases
for the production of -amino acids of pharmacological
interest.
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